Furthermore, based on the KEGG database, Alzheimer’s disease emerged as the most prominent pathway following cerulenin inhibition, implying the potential importance of APP modulation because early-onset Alzheimer’s disease familial forms are linked to APP mutations (72) (Fig. 5E). This evidence concerns the gene APP and early-onset autosomal dominant Alzheimer disease.